GlassScriptPhysician profile
David C Lim
NPI 1023050937
$44,050.89
in general payments reported to CMS, 2019-2025
17 companies · $43K in 2025
The $43K reported for 2025 was more than what 98% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $612 · 2020: $18.08 · 2021: $123 · 2022: $551 · 2024: $246 · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $42K · Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $42,150.00 |
| Food and Beverage | $596.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ancora Heart, INC. | $42,150.00 | 2025 | Accucinch |
| Boston Scientific Corporation | $651.49 | 2019-2024 | |
| Medtronic, INC. | $493.25 | 2022 | |
| Merck Sharp & Dohme LLC | $177.83 | 2021-2025 | Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2025 | Jardiance |
| Baxter Healthcare | $104.91 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Aurinia Pharma U.S., INC. | $85.18 | 2024 | Lupkynis |
| Abbott Laboratories | $59.35 | 2021-2025 | Cardiomems |
| Sanofi-Aventis U.S. LLC | $54.30 | 2020-2021 | |
| Biotronik INC. | $31.93 | 2025 | Biomonitor, Acticor 7 Vr-T Dx, Amvia Edge |
| Novo Nordisk INC | $21.16 | 2021 | |
| Pfizer INC. | $18.24 | 2022 | |
| Astellas Pharma US INC | $16.80 | 2019 | |
| Tactile Systems Technology INC | $16.47 | 2025 | Flexitouch Plus, Nimbl |
| E.R. Squibb & Sons, L.L.C. | $16.24 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.50 | 2022 | |
| Medtronic Vascular, INC. | $14.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.